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Abstract. 
 
This paper presents evidence that a member 
of the L1 family of ankyrin-binding cell adhesion mole-
cules is a substrate for protein tyrosine kinase(s) and 
phosphatase(s), identifies the highly conserved FIGQY 
tyrosine in the cytoplasmic domain as the principal site 
of phosphorylation, and demonstrates that phosphory-
lation of the FIGQY tyrosine abolishes ankyrin-bind-
ing activity. Neurofascin expressed in neuroblastoma 
cells is subject to tyrosine phosphorylation after activa-
tion of tyrosine kinases by NGF or bFGF or inactiva-
tion of tyrosine phosphatases with vanadate or dephos-
tatin. Furthermore, both neurofascin and the related 
molecule Nr-CAM are tyrosine phosphorylated in a de-
velopmentally regulated pattern in rat brain. The 
FIGQY sequence is present in the cytoplasmic domains 
of all members of the L1 family of neural cell adhesion 
molecules. Phosphorylation of the FIGQY tyrosine 
abolishes ankyrin binding, as determined by coimmu-
noprecipitation of endogenous ankyrin and in vitro 
ankyrin-binding assays. Measurements of fluorescence 
recovery after photobleaching demonstrate that phos-
phorylation of the FIGQY tyrosine also increases lat-
eral mobility of neurofascin expressed in neuroblas-
toma cells to the same extent as removal of the 
cytoplasmic domain. Ankyrin binding, therefore, ap-
pears to regulate the dynamic behavior of neurofascin 
and is the target for regulation by tyrosine phosphory-
lation in response to external signals. These findings 
suggest that tyrosine phosphorylation at the FIGQY 
site represents a highly conserved mechanism, used by 
the entire class of L1-related cell adhesion molecules, 
for regulation of ankyrin-dependent connections to the 
spectrin skeleton.
 
V
 
ertebrate
 
 L1, neurofascin, neuroglial cell adhe-
sion molecule (Ng-CAM),
 
1
 
 Ng-CAM–related cell
adhesion molecule (Nr-CAM), and 
 
Drosophila
 
neuroglian are members of a family of nervous system cell
adhesion molecules that possess variable extracellular do-
mains comprised of Ig and fibronectin type III domains
and a relatively conserved cytoplasmic domain (Grumet,
1991; Hortsch and Goodman, 1991; Rathgen and Jessel,
1991; Sonderegger and Rathgen, 1992; Hortsch, 1996).
Members of this family, including a number of alterna-
tively spliced forms, are abundant in the nervous system
during early development as well as in adults. Neurofascin
and Nr-CAM, for example, constitute 
 
z
 
0.5% of the total
membrane protein in adult brain (Davis et al., 1993; Davis
and Bennett, 1994). Cellular functions attributed to the L1
family include axon fasciculation (Stallcup and Beasley,
1985; Landmesser et al., 1988; Brummendorf and Rathjen,
1993; Bastmeyer et al., 1995; Itoh et al., 1995; Magyar-Leh-
mann et al., 1995), axonal guidance (van den Pol and Kim,
1993; Liljelund et al., 1994; Brittis and Silver, 1995; Brittis
et al., 1995; Lochter et al., 1995; Wong et al., 1996), neurite
extension (Chang et al., 1987; Felsenfeld et al., 1994;
Hankin and Lagenaur, 1994; Ignelzi et al., 1994; Williams
et al., 1994
 
a
 
,
 
b
 
,
 
c
 
,
 
d
 
; Doherty et al., 1995; Zhao and Siu,
1995), a role in long term potentiation (Luthl et al., 1994),
synaptogenesis (Itoh et al., 1995), and myelination (Wood
et al., 1990). The potential clinical importance of this
group of proteins has been emphasized by the findings
that mutations in the L1 gene on the X chromosome are
responsible for developmental anomalies including hydro-
cephalus and mental retardation (Rosenthal et al., 1992;
Jouet et al., 1994; Wong et al., 1995).
The conserved cytoplasmic domains of L1 family mem-
bers include a binding site for the membrane skeletal pro-
tein ankyrin. This interaction was first described for neu-
rofascin (Davis et. al., 1993) and subsequently has been
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observed for L1, Nr-CAM (Davis and Bennett, 1994), and
 
Drosophila
 
 neuroglian (Dubreuil et al., 1996). The mem-
brane-binding domain of ankyrin contains two distinct
sites for neurofascin and has the potential to promote lat-
eral association of neurofascin and presumably other L1
family members (Michaely and Bennett, 1995). Nodes of
Ranvier are physiologically relevant axonal sites where
ankyrin and L1 family members collaborate, based on
findings of colocalization of a specialized isoform of ankyrin
with alternatively spliced forms of neurofascin and Nr-
CAM in adults (Davis et al., 1996) as well as in early ax-
onal developmental intermediates (Lambert, S., J. Davis,
P. Michael, and V. Bennett. 1995. 
 
Mol. Biol. Cell.
 
 6:98a).
L1, after homophilic and/or heterophilic binding, partic-
ipates in signal transduction pathways that ultimately are
associated with neurite extension and outgrowth (Ignelzi
et al., 1994; Williams et al., 1994
 
a
 
,
 
b
 
,
 
c
 
,
 
d
 
; Doherty et al.,
1995). L1 copurifies with a serine–threonine protein ki-
nase (Sadoul et al., 1989) and is phosphorylated on a
serine residue that is not conserved among other family
members (Wong et al., 1996). L1 pathway(s) may also in-
volve G proteins, calcium channels, and tyrosine phosphor-
ylation (Williams et al., 1994
 
a
 
,
 
b
 
,
 
c
 
,
 
d
 
; Doherty et al., 1995).
After homophilic interactions, L1 directly activates a ty-
rosine signaling cascade after a lateral association of its
ectodomain with the fibroblast growth factor receptor
(Doherty et al., 1995). Antibodies against L1 have also
been shown to activate protein tyrosine phosphatase activ-
ity in growth cones (Klinz et al., 1995). However, details of
the downstream substrates of L1-promoted phosphoryla-
tion and dephosphorylation and possible roles of the cyto-
plasmic domain are not known.
Tyrosine phosphorylation is well established to modu-
late cell–cell and cell–extracellular matrix interactions in-
volving integrins and their associated proteins (Akiyama
et al., 1994; Arroyo et al., 1994; Schlaepfer et al., 1994; Law
et al., 1996) as well as the cadherins (Balsamo et al., 1996;
Krypta et al., 1996; Brady-Kalnay et al., 1995; Shibamoto
et al., 1995; Hoschuetzky et al., 1994; Matsuyoshi et al.,
1992). For example, the adhesive functions of the calcium-
dependent cadherin cell adhesion molecule are mediated
by a dynamic balance between tyrosine phosphorylation of
 
b
 
-catenin by TrkA and dephosphorylation via the LAR-
type protein tyrosine phosphatase (Krypta et al., 1996). In
this example the regulation of binding among the struc-
tural proteins is the result of a coordination between classes
of protein kinases and protein phosphatases.
This study presents evidence that neurofascin, expressed
in a rat neuroblastoma cell line, is a substrate for both ty-
rosine kinases and protein tyrosine phosphatases at a ty-
rosine residue conserved among all members of the L1
family. Site-specific tyrosine phosphorylation promoted by
both tyrosine kinase activators (NGF and bFGF) and pro-
tein tyrosine phosphatase inhibitors (dephostatin and van-
adate) is a strong negative regulator of the neurofascin–
ankyrin binding interaction and modulates the membrane
dynamic behavior of neurofascin. Furthermore, neurofas-
cin and, to a lesser extent Nr-CAM, are also shown here to
be tyrosine phosphorylated in developing rat brain, imply-
ing a physiological relevance to this phenomenon. These
results indicate that neurofascin may be a target for the co-
ordinate control over phosphorylation that is elicited by
 
protein kinases and phosphatases during in vivo tyrosine
phosphorylation cascades. The consequent decrease in
ankyrin-binding capacity due to phosphorylation of neuro-
fascin could represent a general mechanism among the L1
family members for regulation of membrane–cytoskeletal
interactions in both developing and adult nervous systems.
 
Materials and Methods
 
SDS-PAGE and Immunoblotting
 
SDS–polyacrylamide gel electrophoresis and Western blotting, after trans-
fer of resolved proteins to nitrocellulose, were performed as previously
described (Davis and Bennett, 1983, 1984). Briefly, immunoblots were in-
cubated overnight at 4
 
8
 
C with each primary antibody, washed, and then
incubated with 
 
125
 
I-radiolabeled protein A for 2 h at room temperature.
Blots were visualized via autoradiography. The primary antibodies used
included the anti-phosphotyrosine polyclonal (1:1,000; Upstate Biotech-
nology Inc., Lake Placid, NY), a mucin-specific neurofascin polyclonal
(1:1,000; Davis et al., 1996), the Nr-CAM–specific polyclonal (1:1,000;
Davis et al., 1993), and the brain ankyrin-specific polyclonal antibodies (1:
1,000; Davis and Bennett, 1984).
 
Construct Generation and Transfection of B104 Cells
 
A 600-bp ApaI–EcoRI fragment of wild-type neurofascin cDNA, which
encodes most of the cytoplasmic domain sequence, was subcloned into
pBluescript vector (Stratagene, La Jolla, CA). All deletions and point mu-
tations were carried out using the Exsite PCR-based mutagenesis kit
(Stratagene). The HA epitope was inserted by PCR six amino acids down-
stream of the signal peptide. Mutated constructs were confirmed by DNA
sequencing before the wild-type ApaI–EcoRI sequence was substituted
by the mutated fragment. Both HA epitope-tagged wild-type and cyto-
plasmic domain-truncated neurofascin were subcloned into pCMV vector
at HindIII and BamHI sites. The pCMV vector was derived from pBC12
(Cullen, 1986) with the following modifications: (
 
a
 
) the human IL-2
cDNA sequence (760–1437 bp) was deleted and replaced by a multiple
cloning site containing NheI, SmaI, SalI, and XhoI restriction sites; (
 
b
 
) the
BamHI fragment of the Neo
 
R
 
 gene with an SV40 promotor was inserted
into the BglII site. All the mutated neurofascin cDNA constructs were
subcloned into the pC13 CAT vector at HindIII and NotI sites. The pC13
CAT vector was derived from pOP13 CAT (Stratagene) with the RSV
promotor of pOP13 CAT being replaced by the CMV promotor from
pBC12 at SacII and BglII sites.
Transfection of B104 cells was carried out using lipofectamine (GIBCO
BRL, Gaithersburg, MD). For each 35-mm dish, 5 
 
m
 
g of DNA and 10 
 
m
 
l
(2 mg/ml) of lipofectamine were used following the instructions provided
by GIBCO BRL. 2 d after transfection, 1.5 
 
m
 
g/ml of geneticin (GIBCO
BRL) was added to the media, and colonies of neoresistance cells were
visible 1–2 wk afterward. Approximately 24 single colonies for each con-
struct were chosen and expanded for Western blot analysis to examine
levels of neurofascin expression. Clones with highest expression levels
were used for subsequent studies.
 
Immunoprecipitation of Epitope-tagged Neurofascin
 
After lysis of cells with a modified RIPA buffer (50 mM Tris, pH 7.5, 150
mM NaCl, 0.5% sodium deoxycholate, 1 mM vanadate, 1 mM benzami-
dine, 1 mM PMSF, aprotinin [10 
 
m
 
g/ml], and leupeptin [10 
 
m
 
g/ml]), neuro-
fascin was immunoprecipitated overnight at 4
 
8
 
C from 250–500 
 
m
 
g crude
cell lysate using an HA-specific monoclonal antibody (BAbCO, Berkeley,
CA). Immune complexes were captured with either protein A–Sepharose
(Pierce, Rockford, IL) for SDS-PAGE analysis or with protein A–latex
beads for use in the in vitro ankyrin-binding assays.
 
In Vitro Ankyrin Binding Assays
 
The ability of neurofascin to bind ankyrin was quantitated using an in
vitro ankyrin-binding assay. Beads coated with protein A were used to im-
munoadsorb HA-tagged neurofascin and subsequently used as substrates
for binding of radiolabeled ankyrin. Antibody-coated beads were pre-
pared by coupling 1 mg protein A (Pierce, Rockford, IL) to 100 
 
m
 
g latex
beads (epoxy-activated, 0.4-
 
m
 
m-diam MMA/GMA copolymer beads from 
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Bangs Laboratories, Carmel, IN) for 72 h at 4
 
8
 
C with end over end mixing
in a buffer containing 10 mM Hepes, pH 8.5, 1 mM EGTA, 1 M NaCl, and
1 mM NaN
 
3
 
. Unreacted sites were quenched by adding Tris, pH 8.0, to 100
mM concentration and incubating overnight at 4
 
8
 
C. Nonspecific protein
sites were then blocked by the addition of 10 mg/ml bovine serum albumin
for 2 h. Neurofascin was immunoprecipitated as described above, and the
immune complexes were captured with 20 
 
m
 
l protein A–latex beads. The
amount of each expressed neurofascin isoform used for an assay was nor-
malized after Phosphorimage scanning (Molecular Dynamics, Inc., Sunny-
vale, CA) of crude neurofascin immunoblots of cell extracts for each re-
spective transfected cell line.
The 82-kD membrane binding domain of ankyrin
 
B
 
 was expressed and
purified as described (Davis et al., 1993). Purified 82-kD ankyrin was then
radiolabeled with 
 
125
 
I–Bolton-Hunter reagent (ICN Biochemicals, Irvine,
NY) as previously described for ankyrin and other proteins (Davis et al.,
1993; Davis and Bennett 1983, 1984). Individual neurofascin immunopre-
cipitates were incubated with 20 nM radiolabeled ankyrin plus a given
amount of unlabeled 82-kD ankyrin in a buffer containing 10 mM sodium
phosphate, pH 7.0, 100 mM NaCl, 1 mM EDTA, 2 mg/ml bovine serum al-
bumin, 0.1% Triton X-100, and 1 mM NaN
 
3
 
 for 3 h at 4
 
8
 
C. After incuba-
tion the beads were centrifuged over a 10% sucrose cushion for 15 min at
10,000 
 
g
 
 to separate bound from free radioactivity, and the beads were as-
sayed for 
 
125
 
I in a 
 
g
 
 counter. Each plot depicts one representative com-
plete assay, whereas individual points were determined from the average
of duplicate assays for two individual immunoprecipitates.
 
Cell Culture
 
Transfected and untransfected B104 cells were cultured in high glucose
DMEM containing 10% heat-inactivated fetal bovine serum, 100 U/ml peni-
cillin, and 100 
 
m
 
g/ml streptomycin. All cell culture reagents were pur-
chased from GIBCO BRL. Transfected cells were additionally cultured in
250 
 
m
 
g/ml neomycin (Sigma Chemical Co., St. Louis, MO). For pharmaco-
logical treatments, cells were grown to 50–70% confluency. Cells were cul-
tured on serum-free media for 12 h before treatment with either NGF or
bFGF. Immediately preceding lysis, cells were washed with ice-cold phos-
phate-buffered saline.
 
Fluorescence Recovery after Photobleaching
 
HA epitope-tagged full-length neurofascin, full cytoplasmic-truncated neuro-
fascin, and the FIGQY to F tyrosine mutant were either untreated or
treated with 100 ng/ml NGF for 30 min and then immunolabeled with the
HA-specific monoclonal antibody and an FITC-tagged secondary anti-
body. Cells were subsequently monitored using an Odyssey confocal im-
aging system (Noran Inc., Middleton, WI) mounted on an inverted Nikon
Diaphot microscope in combination with an imaging board (Bitflow,
Woburn, MA) and eye imager calculator software (IO Industries, ON,
Canada), a system that captures images every 16.7 ms. These instruments
were purchased and assembled by Dr. Tobias Meyer (Duke University
Medical Center, Durham, NC). FITC was excited at 488 nm and was mon-
itored above 515 nm. FITC was photobleached using a focused UV laser
at 365 nm. UV laser estimated intensity is 1 mW with an opening time of
10 ms. Fluorescence measurements were determined by the National In-
stitutes of Health Image method of analysis. Triplicate measurements
were taken from each image and averaged followed by subtraction of av-
erage background fluorescence.
 
Detergent Extraction Experiments
 
Denoted neurofascin-expressing B104 cells were either untreated or
treated with 100 ng/ml NGF for 90 min. Control cells were first fixed with
2% paraformaldehyde for 20 min at 4
 
8
 
C and then treated with a PBS
blocking buffer (150 mM NaCl, 30 mM sodium phosphate, pH 7.4, 1%
BSA, and 10% normal goat serum) for 30 min. Control cells were subse-
quently treated with 0.2% Triton X-100 in the PBS blocking solution for
10 min at room temperature and washed with a 0.2% Tween-20 solution
(in the PBS blocking buffer). Alternatively, cells were first treated with
0.2% Triton X-100 in DMEM cell culture media (GIBCO BRL) for 10
min at room temperature and then fixed with 2% paraformaldehyde for
20 min at 4
 
8
 
C. Subsequently, cells were treated with PBS blocking buffer
for 30 min and washed with a 0.2% Tween-20 solution.
After fixation, all cells were incubated overnight at 4
 
8
 
C with the HA-
specific monoclonal antibody (1:1,000). Cells were washed in 0.2%
Tween-20 buffer and then incubated with anti–rabbit FITC-conjugated
secondary antibody (1:2,000) for 2 h at 4
 
8
 
C. Finally, cells were washed
with the 0.2% Tween-20 solution. Confocal images were obtained with an
LSM Zeiss confocal microscope. Fluorescence measurements (intensity/
 
m
 
m
 
2
 
) were obtained from entire cells, and data was analyzed with a Zeiss
analysis software package. Fluorescence intensities for cells treated with
0.2% Triton X-100 before paraformaldehyde fixation are presented rela-
tive to fluorescence intensities for cells that were paraformaldehyde fixed
before Triton X-100 extraction.
 
Analysis of Levels of Phosphotyrosine-immunoreactive 
Neurofascin and Nr-CAM in Developing Rat Brain
 
Rat brain lysates were prepared for embryonic days 15, 17, and 20, postna-
tal days 1, 2, 5–8, 10, 14, and 15, as well as adult rat. Brains were sonicated
in the modified RIPA buffer previously mentioned. Crude lysates (100 
 
m
 
g)
from each day were subjected to SDS-PAGE, and subsequent immuno-
blots were probed with either the mucin-specific neurofascin polyclonal or
an anti–Nr-CAM polyclonal anitbody. Immunoblots were scanned via a
Phosphorimager to determine the amount of neurofascin and Nr-CAM
expressed each day over the developmental period. Subsequently, lysates
were immunoprecipitated either for normalized amounts of neurofascin
or Nr-CAM, and resulting blots were probed with the anti-phosphoty-
rosine antibody. Alternatively, lysates were immunoprecipitated with the
anti-phosphotyrosine antibody (after normalization for neurofascin or Nr-
CAM levels), and subsequent blots were probed with either neurofascin
or Nr-CAM–specific polyclonal antibodies.
 
Results
 
Neurofascin Is Subject to In Vivo
Tyrosine Phosphorylation That Inhibits
Ankyrin-binding Activity
 
Neurofascin and other members of the L1 family of nervous
system cell adhesion molecules have four highly conserved
tyrosine residues in their cytoplasmic domains. The possi-
bility that one or more of these tyrosines are substrates for
phosphorylation by protein kinases was evaluated using
HA epitope-tagged neurofascin stably transfected into the
B104 rat neuroblastoma cell line. Transfected cells were
first treated with activators of receptor tyrosine kinases
(NGF and bFGF) or inhibitors of protein tyrosine phos-
phatases (vanadate and dephostatin), after which neuro-
fascin was immunoprecipitated using the HA-specific mono-
clonal antibody. Subsequent immunoblots were probed
with an anti-phosphotyrosine antibody (Fig. 1 
 
A
 
). The pro-
tein tyrosine phosphatase inhibitor dephostatin (10 
 
m
 
M for
30 min) resulted in strong anti-phosphotyrosine immu-
noreactivity (Fig. 1 
 
A
 
, lane 
 
2
 
), as did sodium metavanadate
(data not shown). Furthermore, incubation of the trans-
fected cells with either nerve growth factor (100 ng/ml for
30 min; Fig. 1 
 
A
 
, lane 
 
3
 
) or basic fibroblast growth factor
(50 ng/ml for 30 min; Fig. 1 
 
A
 
, lane 
 
4
 
) also generated a
strong immunoreactive pool of tyrosine-phosphorylated
neurofascin. Fig. 1 
 
B
 
 quantitates the extent of tyrosine
phosphorylation of neurofascin after treatment of trans-
fected cells with either protein tyrosine phosphatase inhib-
itors (vanadate and dephostatin) or tyrosine kinase activa-
tors (NGF and bFGF) over an extended concentration
range. These results demonstrate that neurofascin is a tar-
get for both protein tyrosine kinases and phosphatases in
vivo when the relevant enzymes are pharmacologically
perturbed in a dose-dependent manner.
The question of whether tyrosine phosphorylation mod-
ulates ankyrin-binding activity of neurofascin was evalu-
ated by determining the effects of phosphorylation on the 
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ability of neurofascin to coimmunoprecipitate endogenous
ankyrin expressed in B104 cells (Fig. 2 
 
A
 
). Neurofascin im-
munoprecipitates were simultaneously enriched for polypep-
tides of 210 and 190 kD as well as a doublet at 102 and 104
kD that crossreact with a brain ankyrin-specific polyclonal
antibody (ankyrin
 
B
 
; Fig. 2 
 
A
 
, lane 
 
2
 
). The 210- and 190-kD
crossreacting polypeptides are of the expected size for
ankyrin with membrane-binding, spectrin-binding, and
COOH-terminal domains. The smaller polypeptides pre-
sumably represent either alternatively spliced variants
missing one or more of these domains or proteolytically
cleaved forms of the 210- and 190-kD polypeptides. Acti-
vation of tyrosine kinases (Fig. 2 
 
A
 
, 
 
NGF
 
 or 
 
bFGF
 
; lanes 
 
4
 
and 
 
5
 
) or inactivation of tyrosine phosphatases (Fig. 2 
 
A
 
,
 
dephostatin
 
; lane 
 
3
 
) completely eliminate the ability of neuro-
fascin to coimmunoprecipitate 210- and 190-kD ankyrin as
well as the 102 and 104-kD crossreacting polypeptides.
Coimmunoprecipitation experiments provide qualita-
tive evidence that tyrosine phosphorylation of neurofascin
abolishes association with endogenous ankyrin in the con-
text of intact cells. These results do not, however, address
whether other cellular factors such as phosphotyrosine-
binding proteins are required for inhibition. Effects of ty-
rosine phosphorylation of neurofascin on binding to ankyrin
were evaluated quantitatively in isolation from other cyto-
solic proteins in an in vitro ankyrin-binding assay. Neurofas-
cin was immunoprecipitated using the HA-specific mono-
clonal antibody and adsorbed to protein A–coated beads,
extensively washed, and then incubated with radiolabeled
ankyrin in a binding assay described in Materials and
Methods.
Neurofascin isolated from cells treated with NGF and
dephostatin exhibits an 
 
z
 
40% reduction in ankyrin-bind-
ing activity compared to neurofascin isolated from un-
treated cells (Fig. 2 
 
B
 
). Scatchard plots (Fig. 2 
 
C
 
) demon-
strate that the inhibition is due to a reduction in capacity
(intercept with the X axis) with no change in affinity
(slope). Tyrosine phosphorylation thus decreased the total
ankyrin-binding capacity, while the ankyrin-binding affin-
ity was unaltered. Such a result can be interpreted to indi-
cate that tyrosine phosphorylation of a given neurofascin
molecule completely abolishes its ability to bind ankyrin,
but only a subpopulation of neurofascin molecules are ty-
rosine phosphorylated. Possible explanations for only par-
tial phosphorylation and, thus, only a partial reduction in
the ankyrin-binding capacity of the total neurofascin popu-
lation include dephosphorylation during isolation, expres-
sion of neurofascin in amounts that exceed the capacity of
tyrosine kinases, and/or the presence of a subpopulation of
neurofascin in a cellular compartment that does not con-
Figure 1. Neurofascin is phosphorylated in vivo by activation of tyrosine kinase signaling cascades or inactivation of tyrosine phos-
phatases. (A) HA epitope-tagged neurofascin was expressed in the rat neuroblastoma B104 cell line. Transfected cells were treated with
one of the following agents for 30 min: dephostatin (10 mM), NGF (100 ng/ml), or bFGF (50 ng/ml). Neurofascin was subsequently im-
munoprecipitated from 500 mg crude cell extract using an HA-specific monoclonal antibody. Immune complexes were then electro-
phoresed on SDS-PAGE and transferred to nitrocellulose. Immunoblots were probed overnight at 48C with a phosphotyrosine-specific
polyclonal antibody followed by incubation with 125I-radiolabeled protein A. Blots were visualized via autoradiography. (B) HA
epitope-tagged neurofascin was expressed in the rat neuroblastoma B104 cell line. Transfected cells were treated with one of the follow-
ing agents (at the noted concentrations) for 30 min: vanadate, dephostatin, NGF, or bNGF. Neurofascin was immunoprecipitated from
500 mg crude cell lysate using the HA-specific monoclonal antibody. Immune complexes were electrophoresed on SDS-PAGE and
transferred to nitrocellulose. Blots were probed with the phosphotyrosine-specific polyclonal antibody followed by incubation with 125I-
radiolabeled protein A. Subsequently, blots were subjected to Phosphorimage scanning to quantitate the extent of tyrosine phosphory-
lation of full length neurofascin under the given treatment conditions.
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tain appropriate tyrosine kinase activity. All three of these
possibilities could be operative and therefore contribute to
partial phosphorylation of isolated neurofascin.
 
Highly Conserved FIGQY Residues in the
Cytoplasmic Domain of Neurofascin Are Required for 
Ankyrin Binding
 
The finding that tyrosine phosphorylation abolished ankyrin-
binding activity suggested the possibility that definition of
the ankyrin-binding determinants of neurofascin would
also lead to identification of the specific site of tyrosine
phosphorylation. The ankyrin-binding site of neurofascin
has been mapped previously to a 35–amino acid stretch in
the COOH-terminal portion of the cytoplasmic domain en-
compassing two highly conserved tyrosine residues (Davis
and Bennett, 1994). Deletion constructs targeted to this
general location, as well as the full length and fully trun-
cated constructs (Fig. 3 
 
A
 
), were evaluated for ankyrin-
binding activity as determined by coimmunoprecipitation
of endogenous ankyrin (Fig. 3 
 
B
 
) and by direct measure-
ment of ankyrin-binding activity of isolated neurofascin
(Fig. 3 
 
C
 
).
Neurofascin with a complete truncation of the cytoplas-
mic domain exhibits no detectable coimmunoprecipitation
with endogenous ankyrin isoforms (Fig. 3 
 
B
 
, lane 
 
4
 
) and
has no binding activity in ankyrin-binding assays (Fig. 3 
 
C
 
).
Deletion of the COOH-terminal 28 residues up to, but not
including, the FIGQ sequence had no effect on ankyrin
binding, while deletion of an additional 11 residues re-
sulted in a major loss of ankyrin-binding activity (Garver,
T., and Q. Ren, unpublished observations). These results
were the basis for a second generation of internally de-
 
min: dephostatin (10 
 
m
 
M), NGF (100 ng/ml), or bFGF (50 ng/ml).
HA-labeled neurofascin (250 
 
m
 
g crude cell lysate) was subse-
quently immunoprecipitated as described above. Immune com-
plexes were captured on protein A–Sepharose beads and electro-
phoresed on SDS-PAGE. Resolved proteins were transferred to
nitrocellulose and incubated overnight at 4
 
8
 
C with a brain ankyrin-
specific polyclonal antibody. After incubation with 
 
125
 
I-labeled
protein A (2 h at 4
 
8
 
C), immunoblots were visualized with autora-
diography. (
 
B
 
) Neurofascin-transfected cells were treated as de-
scribed. HA-labeled neurofascin was immunoprecipitated, and
immune complexes were captured on protein A–labeled latex
beads, washed, and then incubated for 180 min at 4
 
8
 
C with 20 nM
 
125
 
I-radiolabeled, bacterially expressed 82K membrane-binding
domain of the ankyrinB isoform plus a given amount of unlabeled
82K ankyrinB. After incubation the immune complexes were cen-
trifuged over a 10% sucrose cushion to separate bound and free
radioactivity, and the beads were counted on a g counter to assess
levels of ankyrin binding. Each point was obtained by averaging
duplicate assays from individual immunoprecipitations. (C) The
ankyrin binding assay data from above was converted into a form
suitable for Scatchard analysis. The tyrosine phosphorylation–
induced changes in the Scatchard plots (downward shift with no
change in slope) demonstrate that the total ankyrin binding ca-
pacity is decreased with no change in ankyrin binding affinity.
This indicates that phosphorylation of a given neurofascin mole-
cule abolishes its ability to bind ankyrin but does not alter the af-
finity of remaining neurofascin molecules that have not been
phosphorylated and, thus, maintain ankyrin-binding competence.
Figure 2. In vivo activation of tyrosine phosphorylation of neuro-
fascin decreases ankyrin binding capacity. (A) Neurofascin-trans-
fected cells were treated with one of the following agents for 30The Journal of Cell Biology, Volume 137, 1997 708
leted constructs. Deletion of FIGQY region alone leads to
loss of ability to coimmunoprecipitate ankyrin (Fig. 3 B,
lane 3) and an 80% decrease in the level of in vitro ankyrin
binding after immunoadsorption of HA-tagged neurofas-
cin to protein A–coated beads (Fig. 3 C). Neurofascin with
a deletion of an additional seven residues (QFNED-
FIGQY) exhibited a similar 80% reduction in the ankyrin-
binding activity as compared to deletion of FIGQY alone
(Fig. 3 C). However, an internal deletion of 25 residues en-
compassing SDDSLVDY . . . FIGQY (56–81) resulted in a
complete loss of ankyrin-binding activity (Fig. 3 C).
Phosphorylation of the FIGQY Tyrosine Regulates 
Ankyrin Binding of Neurofascin
The results with deletion mutants implicated the five resi-
dues, FIGQY, as essential for full ankyrin binding, with
the NH2-terminal residues SLVDY potentially playing a
secondary role, and suggested that phosphorylation of one
or both of these tyrosines could be the basis for regulation
of ankyrin-binding activity. The role of these tyrosines in
regulation was evaluated by site-directed mutagenesis of
each to phenylalanine (Fig. 3 A) followed by evaluation of
tyrosine phosphorylation and ankyrin-binding activity.
These constructs were stably transfected in B104 cells that
were subsequently treated with NGF, bFGF, or dephosta-
tin. The LVDY to F tyrosine mutant has a tyrosine phos-
phorylation pattern (Fig. 4 A) similar to that seen for the
full length, native neurofascin (Fig. 1 A). However, the
FIGQY to F tyrosine mutant is significantly less phosphory-
lated under the same pharmacological paradigm. Fig. 4 B
quantitatively depicts the effects of the treatments on ty-
rosine phosphorylation. These results identify the FIGQY
tyrosine residue as the primary site of tyrosine phosphory-
lation under the given treatment conditions.
Upon establishing differential phosphorylation patterns
for the two tyrosine residues, we next inspected whether
these two tyrosines are differentially responsible for the
modulation of ankyrin binding. After treatment of the re-
spective transfected cells, neurofascin was immunoprecipi-
tated and used for the in vitro ankyrin-binding assays. The
ankyrin-binding competence of the LVDY to F tyrosine
mutated form of neurofascin is negatively regulated by ty-
rosine phosphorylation to a similar extent as native neuro-
fascin, as determined by the ability to coimmunoprecipi-
tate endogenous ankyrin (Fig. 4 C) and in ankyrin-binding
assays (Fig. 4 D). However, the FIGQY to F neurofascin
mutant isolated from cells treated with NGF, bFGF, or de-
phostatin retains full ankyrin-binding competence based
on the ability to coimmunoprecipitate endogenous ankyrin
(Fig. 4 C) and in ankyrin-binding assays (Fig. 4 D). There-
fore, the FIGQY tyrosine residue appears to be both the
primary site of tyrosine phosphorylation as well as the
phosphorylated site responsible for inhibition of ankyrin-
binding activity.
Lateral Mobility of Neurofascin in Living Cells Is 
Increased by Phosphorylation of the FIGQY Tyrosine
Consequences of ankyrin binding and tyrosine phosphory-
lation on the dynamic behavior of neurofascin in living
cells were evaluated using the technique of FRAP. HA-
tagged neurofascin constructs transfected in B104 cells
were labeled for fluorescence measurements using a mono-
clonal antibody against the HA epitope and an FITC-labeled
secondary antibody. The extent and rate of recovery of
fluorescence at the site of bleaching provide insight about
the mobile fraction and the diffusion properties of immu-
nolabeled neurofascin molecules.
Native neurofascin exhibits essentially no recovery of flu-
orescence after photobleaching, implying its involvement
in highly constraining intermolecular interactions (Fig. 5 A).
In contrast, neurofascin with a fully truncated cytoplasmic
domain exhibits a 10–15% recovery after photobleaching
Figure 3. The highly conserved FIGQY amino acid stretch in the cytoplasmic domain of neurofascin is responsible for ankyrin binding.
(A) Cytoplasmic sequences of L1 family cell adhesion molecules and definition of the neurofascin cytoplasmic domain constructs. (B)
Epitope-tagged neurofascin was immunoprecipitated from 250 mg crude cell lysate, as previously described. Immune complexes were
captured on protein A–Sepharose beads and electrophoresed on SDS-PAGE. Resolved proteins were transferred to nitrocellulose and
incubated overnight at 48C with a brain ankyrin-specific polyclonal antibody. After incubation with 125I-labeled protein A (2 h at 48C),
immunoblots were visualized by autoradiography. (C) HA-epitope tagged neurofascin was expressed in B104 cells and subsequently im-
munoprecipitated from 250 mg crude cell lysate as described previously. Captured immune complexes (on protein A–labeled latex
beads) were then used for the in vitro ankyrin binding assays that have been described above.Garver et al. Tyrosine Phosphorylation of Neurofascin Abolishes Ankyrin Binding 709
(Fig. 5 A), indicating that the cytoplasmic domain of neu-
rofascin makes a small but significant contribution to the
restriction in lateral mobility. The effect of the cytoplasmic
domain presumably results from connections to the spec-
trin skeleton through ankyrin binding. Interactions involv-
ing the ectodomain and/or membrane-spanning domain of
neurofascin, however, probably participate in the majority
of restriction in the lateral mobility of neurofascin.
Treatment of cells expressing full length neurofascin
with NGF under conditions that promote phosphorylation
of the FIGQY tyrosine releases all of the restrictions at-
tributable to the cytoplasmic domain (Fig. 5 A). The frac-
tion that recovers increased from 0 to z10–15% of original
fluorescence levels. The FIGQY tyrosine is responsible for
effects of NGF-promoted tyrosine phosphorylation since
the FIGQY to F mutant is resistant to NGF treatment
(Fig. 5 B) and exhibits the same parameters of fractional
recovery of fluorescence as neurofascin in untreated cells.
Figure 4. FIGQY is the primary site of tyrosine phosphorylation on neurofascin and decreases ankyrin-binding capacity in a site-spe-
cific manner. (A) Neurofascin was immunoprecipitated after a 30-min treatment of the LVDY to F and the FIGQY to F neurofascin
transfected cells with one of the following agents: dephostatin (10 mM), NGF (100 ng/ml), or bFGF (50 ng/ml). Subsequent immunoblots
were probed with the anti-phosphotyrosine antibody overnight at 48C followed by 125I-labeled protein A. (B) The immunoblot visual-
ized above was subjected to Phosphorimage scanning to quantitate the extent of tyrosine phosphorylation of full length neurofascin un-
der the given treatment conditions. The phosphotyrosine signals for both tyrosine mutants are expressed relative to the signals obtained
from treatment of B104 cells expressing native, full length neurofascin (Fig. 1 A). All cells were treated during the same experiment. (C)
Neurofascin was immunoprecipitated from each treatment group for each denoted cell line. Immune complexes were electrophoresed
on SDS-PAGE, and resolved proteins were transferred to nitrocellulose. Blots were incubated with the brain ankyrin-specific poly-
clonal antibody followed by 125I-labeled protein A. (D) Neurofascin was immunoprecipitated following noted treatments from each cell
line. Immune complexes, captured via protein A-labeled latex beads, were then used in the ankyrin binding assay that has been de-
scribed above. The LVDY to F tyrosine mutant, with an intact FIGQY tyrosine residue, is subject to ankyrin binding regulation via ty-
rosine phosphorylation, whereas the FIGQY to F tyrosine mutant is resistant to phosphorylation-induced decreases in the in vitro
ankyrin binding assays.The Journal of Cell Biology, Volume 137, 1997 710
Phosphorylation of the FIGQY Tyrosine Increases 
Detergent Extractability of Neurofascin
Effects of tyrosine phosphorylation on the static in vivo
interaction between forms of expressed neurofascin with
detergent-insoluble components of the spectrin-based cyto-
skeleton were evaluated by analyzing the changes in
rhodamine-labeled, HA epitope-tagged neurofascin inten-
sity after Triton X-100 extraction. Detergent-extraction ex-
periments allow one to examine the steady state interac-
tion between neurofascin and ankyrin and the factors that
may modulate this interaction. B104 cells expressing either
native neurofascin, cytoplasmic domain-deleted neurofas-
cin, or the FIGQY to F tyrosine mutant form of neurofas-
cin were either untreated or treated with 100 ng/ml NGF
for 90 min (Fig. 6, A–D). Cells (extracted with 0.2% Triton
X-100 before fixation) expressing full length neurofascin
exhibited a 65% retention of fluorescence, as compared to
cells fixed before detergent treatment. The fluorescence
was reduced to 28% after treatment with NGF. Neurofas-
cin lacking the cytoplasmic domain was retained at only
10% in the presence of detergent, indicating that NGF
abolished most, but not all, of the interactions of the cyto-
plasmic domain with detergent-insoluble proteins. Inter-
estingly, the reduction in fluorescence due to NGF-induced
tyrosine phosphorylation of native neurofascin is quantita-
tively similar to the reduction in the in vitro binding capac-
ity of neurofascin after tyrosine phosphorylation (Fig. 2
B). In contrast to native neurofascin, cells expressing the
FIGQY to F tyrosine mutant neurofascin were unaffected
by NGF treatment and retained z65% of the label in the
presence and absence of NGF, once again indicating that
this site is the primary one responsible for phosphoty-
rosine-dependent regulation of neurofascin–ankyrin inter-
actions.
Neurofascin and Nr-CAM Are Tyrosine 
Phosphorylated in a Developmentally Regulated Pattern 
in Rat Brain
We wished to determine whether neurofascin and the re-
lated molecule Nr-CAM are tyrosine phosphorylated in
vivo to establish a physiological correlation for what we
have observed in vitro. Consequently, we looked at each
molecule during neuronal development in rat to see if ei-
ther or both of these molecules exhibit a period of phos-
photyrosine immunoreactivity. Fig. 7, A (neurofascin) and
B ( Nr-CAM) demonstrate that both of these molecules
are tyrosine phosphorylated in vivo in a time-dependent
fashion, with the maximal level of phosphotyrosine immu-
noreactivity present during the embyronic period. Phos-
phorimage scanning (data not shown) indicates there is
nearly a threefold reduction in Nr-CAM tyrosine phos-
phorylation from embryonic day 15 to adult brain. In com-
parison, neurofascin phosphotyrosine immunoreactivity is
intense at embryonic day 15. However, this signal is dra-
matically reduced (an z20-fold decline from embryonic
day 15 to adult) over the denoted developmental period.
With respect to neurofascin, it is interesting to note that
the 186-kD isoform is the preferential splice form to be ty-
rosine phosphorylated, even when minimally expressed, as
in embryonic day 15. Immunoprecipitation first with the
anti-phosphotyrosine antibody followed by immunoblot-
ting with either neurofascin or Nr-CAM antibodies ren-
dered qualitatively similar results (data not shown).
Discussion
This paper presents evidence that a member of the L1
Figure 5. Lateral mobility of neurofascin is increased by site-spe-
cific phosphorylation of FIGQY tyrosine. B104 cells expressing
either native neurofascin or the cytoplasmic domain deleted neu-
rofascin (A) or the FIGQY to F tyrosine mutant form of neuro-
fascin (B) were either untreated or treated with 100 ng/ml NGF
for 30 min and then immunolabeled with the HA-specific mono-
clonal antibody and an FITC-tagged secondary antibody. Cells
were subsequently monitored using an Odyssey confocal imaging
system (Noran Inc.) mounted on an inverted Nikon Diaphot mi-
croscope in combination with an imaging board (Bitflow) and eye
imager calculator software (IO Industries), a system that captures
images every 16.7 ms. FITC was excited at 488 nm and was moni-
tored above 515 nm. FITC was photobleached using a focused
UV laser at 365 nm. Fluorescence measurements were deter-
mined by the National Institutes of Health Image method of anal-
ysis.Garver et al. Tyrosine Phosphorylation of Neurofascin Abolishes Ankyrin Binding 711
family of cell adhesion molecules is a substrate for protein
tyrosine kinase(s) and phosphatase(s), identifies the highly
conserved FIGQY tyrosine in the cytoplasmic domain as
the site of phosphorylation, and demonstrates that phos-
phorylation of the FIGQY tyrosine abolishes ankyrin-
binding activity. Phosphorylation of the FIGQY tyrosine
increases lateral mobility of neurofascin expressed in neu-
roblastoma cells to the same extent as removal of the cyto-
plasmic domain and increases detergent extractability of
neurofascin. Ankyrin binding thus modulates the dynamic
behavior of neurofascin and is the target for regulation by
tyrosine phosphorylation–dephosphorylation in response
to external signals. We have further demonstrated that
two L1 family members, neurofascin and Nr-CAM, are
both tyrosine phosphorylated in vivo during embryonic
development, indicating that the functions attributed to ty-
rosine phosphorylation, as determined from our in vitro
studies, are likely to be relevant in vivo as well.
The FIGQY sequence is present in cytoplasmic domains
of all members of the L1 family of nervous system cell ad-
hesion molecules, including a recently described Caenorhab-
ditis elegans partial cDNA sequence. Moreover, ankyrin-
binding activity has been directly demonstrated for mam-
malian neurofascin, L1 and Nr-CAM (Davis and Bennett,
1994), as well as Drosophila neuroglian (Dubreuil et al.,
1996). The findings of this study, therefore, may reflect a
highly conserved mechanism, used by the entire class of
L1-related cell adhesion molecules, of ankyrin-dependent
connections to the spectrin skeleton regulated via site-spe-
cific tyrosine phosphorylation.
The interaction of neurofascin with ankyrin is the first
example of an ankyrin–membrane protein association that
is reversible and subject to dynamic control. The potential
for localized activation or inhibition of cell adhesion mole-
cule interactions with ankyrin could be important for pro-
cesses such as neuronal development, synaptic plasticity,
Figure 6. Phosphorylation
of the FIGQY tyrosine in-
creases detergent extractabil-
ity of neurofascin. (A) Con-
trol cells were first fixed with
2% paraformaldehyde for 20
min at 48C and then treated
with a PBS blocking buffer
(150 mM NaCl, 30 mM so-
dium phosphate, pH 7.4, 1%
BSA, and 10% normal goat
serum) for 30 min. Cells were
subsequently treated with
0.2% Triton X-100 in the
PBS blocking solution for 10
min at room temperature
and washed with a 0.2%
Tween-20 solution. (B) Cells
were first treated with 0.2%
Triton X-100 in DMEM cell
culture media (GIBCO
BRL) for 10 min at room
temperature and then subse-
quently fixed with 2%
paraformaldehyde for 20 min
at 48C. Cells were then incu-
bated with PBS blocking
buffer for 30 min and washed with a 0.2% Tween-20 solution. (C)
Cells were incubated with 100 ng/ml NGF for 90 min before the
treatment described in (B). After fixation, all cells were incu-
bated overnight at 48C with the HA-specific monoclonal antibody
(1:1,000). Cells were washed in 0.2% Tween-20 buffer and subse-
quently incubated with anti–rabbit FITC-conjugated secondary
antibody (1:2,000) for 2 h at 48C. Finally, cells were washed with
the 0.2% Tween-20 solution. Confocal images and fluorescence
intensities (intensity/mm2) were obtained with an LSM Zeiss con-
focal microscope using a Zeiss data analysis software package.
(D) Quantitative analysis of fluorescence intensities. Cells
treated with 0.2% Triton X-100 before paraformaldehyde fixa-
tion are presented relative to fluorescence intensities for cells
that were paraformaldehyde fixed before Triton X-100 extrac-
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and localized assembly of cell adhesion molecule–based
structures in axons. The observation that Nr-CAM and,
more dramatically, neurofascin are preferentially tyrosine
phosphorylated during fetal development indicates phos-
phorylation may play a key role in modulating cytoskeletal
and membrane dynamics during assembly of the nervous
system. Neurofascin and Nr-CAM are targeted to nodes of
Ranvier in myelinated axons where the voltage-dependent
sodium channel and an isoform of ankyrin are highly con-
centrated (Davis et al., 1996). Neurofascin and Nr-CAM
are detected early during the development of nodes of
Ranvier and may direct the subsequent targeting of ankyrin
and the voltage-dependent sodium channel to this site
(Lambert, S., J. Davis, P. Michael, and V. Bennett. 1995.
Mol. Biol. Cell. 6:98a). Dephosphorylation by a protein ty-
rosine phosphatase localized at nodes of Ranvier is an at-
tractive mechanism for localized activation of ankyrin-bind-
ing activity of neurofascin and Nr-CAM. The biological
significance of a reversible ankyrin-binding activity for L1-
like cell adhesion molecules could be evaluated using
FIGQY to F mutants, which are resistant to inhibition of
ankyrin binding by tyrosine phosphorylation.
Consequences of ankyrin association with neurofascin
include the potential for stabilizing laterally associated
neurofascin oligomers in addition to providing a connec-
tion to spectrin. The membrane-binding domain of ankyrin
contains two independent binding sites for neurofascin,
and, in principle, could promote assembly of neurofascin
dimers (Michaely and Bennett, 1995). Transcellular inter-
actions of neurofascin, by analogy with cadherins, could be
promoted by lateral association of neurofascin molecules.
These considerations suggest the testable hypotheses that
ankyrin binding could enhance cell–cell interactions medi-
ated by neurofascin and other L1 family members and that
elevation of tyrosine phosphorylation would reverse acti-
vation of cell adhesion by ankyrin.
A question remains how the phosphorylation event pro-
hibits neurofascin–ankyrin association. The fact that the
key tyrosine residue is directly adjacent to the primary
amino acid sequence established in this study as required
for ankyrin binding may mean that tyrosine phosphoryla-
tion of neurofascin blocks ankyrin binding directly through
steric hinderance or by the introduction of electrostatic re-
pulsion. Another possibility is that ankyrin associates pref-
erentially with neurofascin dimers and that phosphoryla-
tion inhibits neurofascin dimerization. These issues could
be addressed by characterizing the stoichiometries of neu-
rofascin–ankyrin complexes in solution.
A possible consequence of tyrosine phosphorylation of
neurofascin, in addition to inhibition of ankyrin binding, is
the activation of a phosphotyrosine-specific binding pro-
tein. However, consensus sequences for SH2 and PTB pro-
teins differ from the neurofascin sequence flanking the
FIGQY region. Putative phosphotyrosine-binding pro-
teins specific for phosphorylated members of the L1 fam-
ily, therefore, may be distinct from currently established
candidates.
Previous studies (Williams et al., 1994a,b,c,d; Doherty et
al., 1995; Dubreuil et al., 1996) have recognized that L1
family members can directly act as signal transducers. We
are providing evidence of an L1 family member as a sub-
strate for enzyme(s) in tyrosine signaling cascade(s). There-
fore, it will be important in future work to elucidate the
specific tyrosine protein kinases and phosphatases that
control the phosphorylation state of neurofascin. Both
NGF and bFGF promoted phosphorylation of neurofas-
cin, suggesting either neurofascin is recognized by at least
two distinct receptor protein kinases or that other protein
kinase(s) activated downstream are involved. Another
point of interest includes determining which protein tyro-
sine phosphatase(s) are involved in dephosphorylating
neurofascin. Recent work has focused on a class of receptor
protein tyrosine phosphatases (for review see Brady-Kalnay
et al., 1995). Some integral protein tyrosine phosphatases
(LAR-PTP, for example) are homologous to cell adhesion
molecules of the Ig superfamily. Interestingly, Krypta et al.
(1996) have shown that a direct association between LAR-
PTP and cadherins helps to control cadherin adhesive
functions. Although the cadherins are distinct from the L1
family, this direct association may represent a common
mechanism by which cell adhesion molecules, through lat-
eral association with a structurally related receptor protein
tyrosine phosphatase, may be dephosphorylated.
Modulation of the interaction between ankyrin and the
Figure 7. Neurofascin and Nr-CAM are tyrosine phosphorylated
in developing rat brain. Neurofascin (A) or Nr-CAM (B) were
immunoprecipitated, from each noted time point, with either the
mucin-specific neurofascin polyclonal antibody (A) or the Nr-
CAM–specific polyclonal antibody (B) after normalization for
expressed neurofascin or Nr-CAM levels, respectively (see Mate-
rials and Methods). Resolved proteins were transferred to nitro-
cellulose, and blots were incubated overnight at 48C with the anti-
phosphotyrosine antibody.Garver et al. Tyrosine Phosphorylation of Neurofascin Abolishes Ankyrin Binding 713
various members of L1 cell adhesion molecules may play a
critical role in mediating reversible assembly of a variety
of transcellular complexes in the developing and adult ner-
vous systems. The next step will be to extend the findings
of this study to more physiologically relevant systems.
Both tyrosine phosphorylation-resistant neurofascin mu-
tants and forms of neurofascin lacking ankyrin-binding ac-
tivity should provide precisely defined molecular tools for
future work.
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